Network News

Further Information in German below. Promega entwickelt neues Enzym zur signifikanten Reduktion von Stutter-Artefakten in der forensischen DNA-Analyse Madison, WI USA. (30. September 2024)  Forschende der Promega Corporation haben ein neues Enzym entwickelt, das störende Stutter-Artefakte in der forensischen DNA-Analyse nahezu vollständig eliminiert. Dieses Enzym erleichtert erheblich die Dekonvolution von Mischspuren und ermöglicht Forensikerinnen und Forensikern, […]

Success for the NMI spin-off immuneAdvice: the startup took first place in the Young Scientists Pitch Competition at the bioRN Annual Conference on Wednesday, October 9, 2024. Dr. Björn Tränkle, one of the founders, presented the business idea. The vision of immuneAdvice is the early response monitoring and control of immunotherapies with the so-called ICE-T […]

YUMAB GmbH (“YUMAB”), a leading antibody discovery CRO headquartered in Braunschweig, Germany, and MOLCURE Inc. (“MOLCURE”), an AI-driven drug discovery company based in Kawasaki, Japan, announced their on-going collaboration now includes advancing the application of zero-shot AI technology for antibody discovery. The collaboration brings together complementary expertise and technologies. MOLCURE has a decade of experience […]

Heidelberg, Germany, 24.09.2024 – RHEACELL today announced that the U.S. Food and Drug Administration (FDA) approved the companies blinded, multi-centric Phase-3 trial (NCT06489028) to investigate allo-APZ2-CVU in patients with chronic venous ulcers (CVU). Allo-APZ2-CVU is a first-in-class stem cell therapy leveraging ABCB5-positive mesenchymal stem cells (MSCs) to treat patients with severe immune and inflammation-driven diseases […]

We are pleased to announce significant news: the first sustainable and biodegradable pregnancy test in Europe developed by Zamann Pharma Support, under the Terra Trust house brand, has been nominated for the prestigious DQS Sustainability Award 2024 in the “Sustainable Innovation” category. This nomination is a confirmation of their tireless commitment to environmental protection and […]

The Helmholtz Association and the Stifterverband für die Deutsche Wissenschaft have awarded the biochemist Oliver Bruns (NCT/UCC Dresden and DKFZ) and the chemist Ellen Sletten (UCLA) with the Helmholtz High Impact Award 2024. Both are honored for their research on a new medical imaging technology in the short-wave infrared (SWIR) range, which has the potential […]

The new research team led by Dr. Stefanie Bärthel will work on developing next-generation immunotherapies by leveraging the antitumor effects of neutrophils. Heidelberg, September 17, 2024. BioMed X, a German biomedical research institute, announced the start of a new research team at the BioMed X Institute in Heidelberg, Germany, the institute’s first joint research project […]

In recognition of his outstanding scientific achievements, Joachim Spatz, Managing Director of the Max Planck Institute for Medical Research in Heidelberg, honored Hendrik Dietz from the Technical University of Munich with the Institute’s Otto Meyerhof Medal. In a festive ceremony at the Max Planck Institute for Medical Research (MPImF) in Heidelberg, Joachim Spatz awarded the […]

Every year, millions of people worldwide are infected with malaria, and several hundred thousand die as a result of the infection. Due to widespread resistance, neither the disease can be reliably treated nor can its vectors be effectively combated. A vaccine is also still a long way off. Dr Franziska Hentzschel holds a position as […]